Abstract
This chapter focuses on RNA in situ hybridization (RNA ISH) technology and applications of RNA ISH in anatomic pathology. Over the last several years, novel RNA ISH methods that utilize signal amplification, such as RNAscope, have dramatically improved the performance of the approach and led to the development of RNA ISH assays for a variety of applications across anatomic pathology, with a focus on infectious disease detection and tumor characterization. One of the most important applications is the detection of high-risk types of HPV in head and neck squamous cell carcinomas, an application with both high diagnostic sensitivity and specificity when compared to other detection techniques, such as DNA ISH and p16 immunohistochemistry (IHC). Identification of both high-risk and low-risk types of HPV in cervical biopsy specimens to improve diagnostic accuracy for low-grade squamous intraepithelial lesions (LGSILs) is another application with demonstrated clinical utility. Other compelling infectious disease applications include detection of cytomegalovirus (CMV) and Epstein-Barr virus (EBV), with assays for important pathogens like SARS-CoV-2 and Mycobacterium tuberculosis showing great promise. Applications of RNAscope in tumor characterization have become increasingly important, including detection of albumin expression in hepatocellular carcinoma and intrahepatic cholangiocarcinoma, and detection of KIM-1 expression in renal cell carcinoma. Furthermore, RNAscope has been shown to detect immunoglobulin kappa and lambda light chains in the assessment of clonality in lymphoid proliferations with similar diagnostic sensitivity and specificity to flow cytometry. Finally, several recent reports indicate that RNAscope can be used to detect gene fusions and amplifications, such as those involving the ALK and MDM2 genes, potentially providing an alternative approach to fluorescent in situ hybridization (FISH) and other technologies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
John HA, Birnstiel ML, Jones KW. RNA-DNA hybrids at the cytological level. Nature. 1969;223(5206):582–7.
Angerer LM, Angerer RC. Detection of poly A+ RNA in sea urchin eggs and embryos by quantitative in situ hybridization. Nucleic Acids Res. 1981;9(12):2819–40.
Segal GH, Shick HE, Tubbs RR, Fishleder AJ, Stoler MH. In situ hybridization analysis of lymphoproliferative disorders. Assessment of clonality by immunoglobulin light-chain messenger RNA expression. Diagn Mol Pathol. 1994;3(3):170–7.
Larsson LI, Hougaard DM. Detection of gastrin and its messenger RNA in Zollinger-Ellison tumors by non-radioactive in situ hybridization and immunocytochemistry. Histochemistry. 1992;97(2):105–10.
Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2012;14(1):22–9.
Baker AM, Van Noorden S, Rodriguez-Justo M, Cohen P, Wright NA, Lampert IA. Distribution of the c-MYC gene product in colorectal neoplasia. Histopathology. 2016;69(2):222–9.
Randen-Brady R, Carpen T, Jouhi L, Syrjanen S, Haglund C, Tarkkanen J, et al. In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer. Hum Pathol. 2019;90:97–105.
Mirghani H, Casiraghi O, Amen F, He M, Ma XJ, Saulnier P, et al. Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice. Mod Pathol. 2015;28(12):1518–27.
Rahimi S, Akaev I, Brennan PA, Virgo A, Marani C, Gomez RS, et al. A proposal for classification of oropharyngeal squamous cell carcinoma: morphology and status of HPV by immunohistochemistry and molecular biology. J Oral Pathol Med. 2020;49(2):110–6.
Craig SG, Anderson LA, Schache AG, Moran M, Graham L, Currie K, et al. Recommendations for determining HPV status in patients with oropharyngeal cancers under TNM8 guidelines: a two-tier approach. Br J Cancer. 2019;120(8):827–33.
Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, et al. The Lower Anogenital Squamous Terminology Standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arch Pathol Lab Med. 2012;136(10):1266–97.
Mills AM, Coppock JD, Willis BC, Stoler MH. HPV E6/E7 mRNA in situ hybridization in the diagnosis of cervical low-grade squamous intraepithelial lesions (LSIL). Am J Surg Pathol. 2018;42(2):192–200.
Coppock JD, Willis BC, Stoler MH, Mills AM. HPV RNA in situ hybridization can inform cervical cytology-histology correlation. Cancer Cytopathol. 2018;126(8):533–40.
Zhang B, Shi J, Liu H, Monroe R, Lin F. Utility of HPV E6 and E7 mRNA in situ hybridization in diagnosing cervical low-grade squamous intraepithelial lesion (LSIL) [USCAP abstract 1160]. Mod Pathol. 2019;32(S2):135.
Zelonis M, Shi J, Liu H, Monroe R. Detection of cervical squamous dysplasia on cell blocks prepared from Pap test samples – a combined study based on morphology, HPV detection by RNA in situ hybridization, and immunohistochemical stains for p16 and Ki-67 (USCAP abstract 455) Lab Invest. 2020;100:447.
Shahid M, Mubeen A, Tse J, Kakar S, Bateman AC, Borger D, et al. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms. Am J Surg Pathol. 2015;39(1):25–34.
Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, et al. The ability to diagnose intrahepatic cholangiocarcinoma definitively using novel branched DNA-enhanced albumin RNA in situ hybridization technology. Ann Surg Oncol. 2016;23(1):290–6.
Avadhani V, Siddiqui MT, Lawson D, Cohen C. Albumin RNA in situ hybridization in hepatocellular carcinomas and other neoplastic and non-neoplastic tissue: can this be a clinically useful marker? [USCAP abstract 632]. Mod Pathol. 2017;30(S2):159A.
Avadhani V, Siddiqui MT, Lawson D, Cohen C, Krasinskas A. Is albumin RNA in situ hybridization (RISH) a reliable marker for intrahepatic cholangiocarcinomas? [USCAP abstract 1657]. Mod Pathol. 2017;30(S2):413A.
Lehrke HBJ, Mounajjed T, Said S, Yasir S, Chandan VS, Shah S, Smyrk T, Zhang L, Graham R. Albumin in-situ hybridization may be positive in adenocarcinomas and other tumors from diverse sites [USCAP abstract 1680]. Mod Pathol. 2017;30(S2):419A.
Lin F, Shi J, Wang HL, Ma XJ, Monroe R, Luo Y, et al. Detection of albumin expression by RNA in situ hybridization is a sensitive and specific method for identification of hepatocellular carcinomas and intrahepatic cholangiocarcinomas. Am J Clin Pathol. 2018;150(1):58–64.
Askan G, Deshpande V, Klimstra DS, Adsay V, Sigel C, Shia J, et al. Expression of markers of hepatocellular differentiation in pancreatic acinar cell neoplasms: a potential diagnostic pitfall. Am J Clin Pathol. 2016;146(2):163–9.
Lok T, Chen L, Lin F, Wang HL. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma. Hum Pathol. 2014;45(2):394–400.
Liu H, Shi J, Lin F. The potential diagnostic utility of TROP-2 in thyroid neoplasms. Appl Immunohistochem Mol Morphol. 2017;25(8):525–33.
Lin F, Zhang PL, Yang XJ, Shi J, Blasick T, Han WK, et al. Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma. Am J Surg Pathol. 2007;31(3):371–81.
Sarami I, Shi J, Lin B, Liu H, Monroe R, Lin F. Evaluation of human kidney injury molecule-1 (hKIM-1) expression in tumors from various organs by mRNA in situ hybridization. Am J Clin Pathol. 2021;156(2):288–99. https://doi.org/10.1093/ajcp/aqaa236.
Liu H, Shi J, He MX, Luo L, Lin F. RNA in situ hybridization is a more sensitive method than immunohistochemistry in detection of GCDFP15 expression in breast carcinomas [CAP poster 161]. Arch Pathol Lab Med. 2016;250(9):e108.
Shi J, Liu H, Ma XJ, Chen Z, He MX, Luo Y, et al. Ribonucleic acid in situ hybridization is a more sensitive method than immunohistochemistry in detection of thyroid transcription factor 1 and napsin A expression in lung adenocarcinomas. Arch Pathol Lab Med. 2016;140(4):332–40.
Bahrami A, Weiss SW, Montgomery E, Horvai AE, Jin L, Inwards CY, et al. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia. Am J Surg Pathol. 2009;33(9):1348–54.
Carter JM, Caron BL, Dogan A, Folpe AL. A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors. Am J Surg Pathol. 2015;39(1):75–83.
Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096–100.
Jaeger T, Ring J, Andres C. Histological, immunohistological, and clinical features of Merkel cell carcinoma in correlation to Merkel cell polyomavirus status. J Skin Cancer. 2012;2012:983421.
Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst. 2009;101(13):938–45.
Moshiri AS, Doumani R, Yelistratova L, Blom A, Lachance K, Shinohara MM, et al. Polyomavirus-negative Merkel cell carcinoma: a more aggressive subtype based on analysis of 282 cases using multimodal tumor virus detection. J Invest Dermatol. 2017;137(4):819–27.
Wang L, Harms PW, Palanisamy N, Carskadon S, Cao X, Siddiqui J, et al. Age and gender associations of virus positivity in Merkel cell carcinoma characterized using a novel RNA in situ hybridization assay. Clin Cancer Res. 2017;23(18):5622–30.
Nakajima N, Yoshizawa A, Kondo K, Rokutan-Kurata M, Hirata M, Furuhata A, et al. Evaluating the effectiveness of RNA in-situ hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement. Histopathology. 2017;71(1):143–9.
Lin F, Shi J, Chen ZE, Yin H, Monroe R, Liu H. Detection of anaplastic lymphoma kinase (ALK) gene rearrangement by RNA in situ hybridization in lung adenocarcinomas [USCAP abstract 1852]. Mod Pathol. 2019;32(S2).
Kulkarni AS, Wojcik JB, Chougule A, Arora K, Chittampalli Y, Kurzawa P, et al. MDM2 RNA in situ hybridization for the diagnosis of atypical lipomatous tumor: a study evaluating DNA, RNA, and protein expression. Am J Surg Pathol. 2019;43(4):446–54.
Guo L, Wang Z, Anderson CM, Doolittle E, Kernag S, Cotta CV, et al. Ultrasensitive automated RNA in situ hybridization for kappa and lambda light chain mRNA detects B-cell clonality in tissue biopsies with performance comparable or superior to flow cytometry. Mod Pathol. 2018;31(3):385–94.
Tubbs RR, Wang H, Wang Z, Minca EC, Portier BP, Gruver AM, et al. Ultrasensitive RNA in situ hybridization for detection of restricted clonal expression of low-abundance immunoglobulin light chain mRNA in B-cell lymphoproliferative disorders. Am J Clin Pathol. 2013;140(5):736–46.
Minca EC, Wang H, Wang Z, Lanigan C, Billings SD, Luo Y, et al. Detection of immunoglobulin light-chain restriction in cutaneous B-cell lymphomas by ultrasensitive bright-field mRNA in situ hybridization. J Cutan Pathol. 2015;42(2):82–9.
Wang Z, Cook JR. IRTA1 and MNDA expression in marginal zone lymphoma: utility in differential diagnosis and implications for classification. Am J Clin Pathol. 2019;151(3):337–43.
Lin F, Shi J, Lin B, Monroe R. Detection of BK polyomavirus in allograft renal biopsies: comparison of diagnostic sensitivity and specificity of RNA in situ hybridization vs. immunohistochemistry [CAP poster 149]. Arch Pathol Lab Med. 2018;142(9):e98.
Roe CJ, Siddiqui MT, Lawson D, Cohen C. RNA in situ hybridization for Epstein-Barr virus and cytomegalovirus: comparison with in situ hybridization and immunohistochemistry. Appl Immunohistochem Mol Morphol. 2019;27(2):155–9.
Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358(6369):1443–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive licence to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lin, F., Kim, J., Monroe, R. (2022). RNA In Situ Hybridization: Applications in Anatomic Pathology. In: Lin, F., Prichard, J.W., Liu, H., Wilkerson, M.L. (eds) Handbook of Practical Immunohistochemistry. Springer, Cham. https://doi.org/10.1007/978-3-030-83328-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-83328-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-83327-5
Online ISBN: 978-3-030-83328-2
eBook Packages: MedicineMedicine (R0)